F.D.A. Asks If Faulty Blood Monitor Tainted Xarelto Approval

A legal brief says Johnson & Johnson has been asked whether Alere’s recalled INRatio blood-testing monitor compromised the anticlotting drug’s trial.











from NYT > Health http://ift.tt/1QuQH1O
via health&fitness